Study Title: A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Brian Hess, at hessbr@musc.edu.Study Coordinator, Julia Smith, at smijuli1@musc.edu.Trial opened at the following institutions: Medical University of South Carolina